Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jacqui Marzec is active.

Publication


Featured researches published by Jacqui Marzec.


The FASEB Journal | 2007

Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury

Jacqui Marzec; Jason D. Christie; Sekhar P. Reddy; Anne E. Jedlicka; Hue Vuong; Paul N. Lanken; Richard Aplenc; Tae Yamamoto; Masayuki Yamamoto; Hye Youn Cho; Steven R. Kleeberger

We recently used positional cloning to identify the transcription factor Nrf2 (NF‐E2 related factor 2) as a susceptibility gene in a murine model of oxidant‐induced acute lung injury (ALI). NRF2 binds to antioxidant response elements (ARE) and up‐regulates protective detoxifying enzymes in response to oxidative stress. This led us to investigate NRF2 as a candidate susceptibility gene for risk of development of ALI in humans. We identified multiple single nucleotide polymorphisms (SNPs) by resequencing NRF2 in ethnically diverse subjects, and one (—617 C/A) significantly (P< 0.001) diminished luciferase activity of promoter constructs containing the SNP and significantly decreased the binding affinity (P<0.001) relative to the wild type at this locus (—617 CC). In a nested case‐control study, patients with the —617 A SNP had a significantly higher risk for developing ALI after major trauma (OR 6.44; 95% CI 1.34, 30.8;P=0.021) relative to patients with the wild type (—617 CC). This translational investigation provides novel insight into the molecular mechanisms of susceptibility to ALI and may help to identify patients who are predisposed to develop ALI under at risk conditions, such as trauma and sepsis. Furthermore, these findings may have important implications in other oxidative stress related illnesses.–Marzec J. M., Christie, J. D., Reddy, S. P., Jedlicka, A. E., Vuong, H., Lanken, P. N., Aplenc, R., Yamamoto, T., Yamamoto, M., Cho, H.‐Y., Klee‐berger S. R. Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. FASEB J. 21, 2237–2246 (2007)


Journal of Clinical Investigation | 2015

TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization

Mauricio T. Caballero; M. Elina Serra; Patricio L. Acosta; Jacqui Marzec; Luz Gibbons; Maximiliano Salim; A. M. Rodríguez; Andrea Reynaldi; Alejandro M. Garcia; Daniela Bado; Ursula J. Buchholz; Diego R. Hijano; Silvina Coviello; Dawn C. Newcomb; Miguel Bellabarba; Fausto M. Ferolla; Romina Libster; Ada Berenstein; Susana Siniawaski; Valeria Blumetti; Marcela Echavarria; Leonardo Araújo Pinto; Andrea Lawrence; M. Fabiana Ossorio; Arnoldo Grosman; Cecilia G. Mateu; Carola Bayle; Alejandra Dericco; Mariana Pellegrini; Ignacio Igarza

While 30%-70% of RSV-infected infants develop bronchiolitis, 2% require hospitalization. It is not clear why disease severity differs among healthy, full-term infants; however, virus titers, inflammation, and Th2 bias are proposed explanations. While TLR4 is associated with these disease phenotypes, the role of this receptor in respiratory syncytial virus (RSV) pathogenesis is controversial. Here, we evaluated the interaction between TLR4 and environmental factors in RSV disease and defined the immune mediators associated with severe illness. Two independent populations of infants with RSV bronchiolitis revealed that the severity of RSV infection is determined by the TLR4 genotype of the individual and by environmental exposure to LPS. RSV-infected infants with severe disease exhibited a high GATA3/T-bet ratio, which manifested as a high IL-4/IFN-γ ratio in respiratory secretions. The IL-4/IFN-γ ratio present in infants with severe RSV is indicative of Th2 polarization. Murine models of RSV infection confirmed that LPS exposure, Tlr4 genotype, and Th2 polarization influence disease phenotypes. Together, the results of this study identify environmental and genetic factors that influence RSV pathogenesis and reveal that a high IL-4/IFN-γ ratio is associated with severe disease. Moreover, these molecules should be explored as potential targets for therapeutic intervention.


Environmental Health Perspectives | 2010

Protective role of interleukin-10 in ozone-induced pulmonary inflammation.

Gillian S. Backus; Reuben Howden; Jennifer Fostel; Alison K. Bauer; Hye Youn Cho; Jacqui Marzec; David B. Peden; Steven R. Kleeberger

Background The mechanisms underlying ozone (O3)-induced pulmonary inflammation remain unclear. Interleukin-10 (IL-10) is an anti-inflammatory cytokine that is known to inhibit inflammatory mediators. Objectives We investigated the molecular mechanisms underlying interleuken-10 (IL-10)–mediated attenuation of O3-induced pulmonary inflammation in mice. Methods Il10-deficient (Il10−/−) and wild-type (Il10+/+) mice were exposed to 0.3 ppm O3 or filtered air for 24, 48, or 72 hr. Immediately after exposure, differential cell counts and total protein (a marker of lung permeability) were assessed from bronchoalveolar lavage fluid (BALF). mRNA and protein levels of cellular mediators were determined from lung homogenates. We also used global mRNA expression analyses of lung tissue with Ingenuity Pathway Analysis to identify patterns of gene expression through which IL-10 modifies O3-induced inflammation. Results Mean numbers of BALF polymorphonuclear leukocytes (PMNs) were significantly greater in Il10−/− mice than in Il10+/+ mice after exposure to O3 at all time points tested. O3-enhanced nuclear NF-κB translocation was elevated in the lungs of Il10−/− compared with Il10+/+ mice. Gene expression analyses revealed several IL-10–dependent and O3-dependent mediators, including macrophage inflammatory protein 2, cathepsin E, and serum amyloid A3. Conclusions Results indicate that IL-10 protects against O3-induced pulmonary neutrophilic inflammation and cell proliferation. Moreover, gene expression analyses identified three response pathways and several genetic targets through which IL-10 may modulate the innate and adaptive immune response. These novel mechanisms of protection against the pathogenesis of O3-induced pulmonary inflammation may also provide potential therapeutic targets to protect susceptible individuals.


Pharmacogenetics and Genomics | 2012

Polymorphisms in the transcription factor NRF2 and forearm vasodilator responses in humans

Ewa D. Marczak; Jacqui Marzec; Darryl C. Zeldin; Steven R. Kleeberger; Nancy J. Brown; Mias Pretorius; Craig R. Lee

Objective Oxidative stress is integral to the development of endothelial dysfunction and cardiovascular disease. As NRF2 is a key transcription factor in antioxidant defense, we aimed to determine whether polymorphisms within the promoter region of the gene encoding NRF2 (NFE2L2) would significantly modify vasodilator responses in humans. Methods Associations between the −653A/G (rs35652124), −651G/A (rs6706649), and −617C/A (rs6721961) polymorphisms within the NFE2L2 promoter and vascular function were evaluated in healthy African-American (n=64) and white (n=184) individuals. Forearm blood flow (FBF) was measured by strain-gauge venous occlusion plethysmography at baseline and in response to incremental doses of bradykinin or sodium nitroprusside. Forearm vascular resistance (FVR) was calculated as the mean arterial pressure/FBF. Results In African Americans, −653G variant allele carriers had significantly lower FBF and higher FVR under basal conditions as well as in response to bradykinin or sodium nitroprusside compared with wild-type individuals (P<0.05 for each comparison). In whites, although no significant associations were observed with the −653A/G genotype, −617A variant allele carriers had significantly higher FVR at baseline and in response to bradykinin or sodium nitroprusside compared with wild-type individuals (P<0.05 for each comparison). The −651G/A polymorphism was not associated with vasodilator responses in either racial group. Conclusion Polymorphisms within the NFE2L2 promoter were associated with impaired forearm vasodilator responses in an endothelial-independent manner, suggesting an important role of NRF2 in the regulation of vascular function in humans.


Free Radical Biology and Medicine | 2015

Functional polymorphisms in Nrf2: implications for human disease

Hye-Youn Cho; Jacqui Marzec; Steven R. Kleeberger

Nuclear factor (erythroid derived)-2 like 2 (NFE2L2), also known as nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2), is a ubiquitous transcription factor essential for protecting cells and tissues from oxidative stress-induced injury. Positional cloning and studies with Nrf2 knockout mice have identified important roles for this transcription factor in disease phenotypes for many organ systems. Studies have also characterized the means through which human Nrf2 is regulated and the mechanisms of interaction with antioxidant response elements (ARE) in promoters of effector genes. Moreover, single nucleotide polymorphisms (SNPs) in Nrf2 have been identified and evaluated for effects on gene expression and function, and translational investigations have sought to determine whether loss of function SNPs associate with disease progression. In this review, we present 1) an overview of the human Nrf2 gene and protein domain, 2) identification of genetic mutations in Nrf2 and associations of the mutations with multiple diseases, and 3) the role of somatic mutations in Nrf2 in diseases, primarily various cancers.


Antioxidants & Redox Signaling | 2015

Association of Nrf2 polymorphism haplotypes with acute lung injury phenotypes in inbred strains of mice.

Hye Youn Cho; Anne E. Jedlicka; Wesley Gladwell; Jacqui Marzec; Zackary R. McCaw; Rachelle J. Bienstock; Steven R. Kleeberger

AIMS Nrf2 is a master transcription factor for antioxidant response element (ARE)-mediated cytoprotective gene induction. A protective role for pulmonary Nrf2 was determined in model oxidative disorders, including hyperoxia-induced acute lung injury (ALI). To obtain additional insights into the function and genetic regulation of Nrf2, we assessed functional single nucleotide polymorphisms (SNPs) of Nrf2 in inbred mouse strains and tested whether sequence variation is associated with hyperoxia susceptibility. RESULTS Nrf2 SNPs were compiled from publicly available databases and by re-sequencing DNA from inbred strains. Hierarchical clustering of Nrf2 SNPs categorized the strains into three major haplotypes. Hyperoxia susceptibility was greater in haplotypes 2 and 3 strains than in haplotype 1 strains. A promoter SNP -103 T/C adding an Sp1 binding site in haplotype 2 diminished promoter activation basally and under hyperoxia. Haplotype 3 mice bearing nonsynonymous coding SNPs located in (1862 A/T, His543Gln) and adjacent to (1417 T/C, Thr395Ile) the Neh1 domain showed suppressed nuclear transactivation of pulmonary Nrf2 relative to other strains, and overexpression of haplotype 3 Nrf2 showed lower ARE responsiveness than overexpression of haplotype 1 Nrf2 in airway cells. Importantly, we found a significant correlation of Nrf2 haplotypes and hyperoxic lung injury phenotypes. INNOVATION AND CONCLUSION The results indicate significant influence of Nrf2 polymorphisms and haplotypes on gene function and hyperoxia susceptibility. Our findings further support Nrf2 as a genetic determinant in ALI pathogenesis and provide useful tools for investigators who use mouse strains classified by Nrf2 haplotypes to elucidate the role for Nrf2 in oxidative disorders.


The FASEB Journal | 2014

A genetic model of differential susceptibility to human respiratory syncytial virus (RSV) infection

Xuting Wang; Jacqui Marzec; M. Elina Serra; Douglas A. Bell; Fernando P. Polack; Steven R. Kleeberger

Respiratory syncytial virus (RSV) is the primary cause of lower respiratory tract infection during childhood and causes severe symptoms in some patients, which may cause hospitalization and death. Mechanisms for differential responses to RSV are unknown. Our objective was to develop an in vitro model of RSV infection to evaluate interindividual variation in response to RSV and identify susceptibility genes. Populations of human‐derived HapMap lymphoblastoid cell lines (LCLs) were infected with RSV. Compared with controls, RSV‐G mRNA expression varied from ~1‐ to 400‐fold between LCLs. Basal expression of a number of gene transcripts, including myxovirus (influenza virus) resistance 1 (MX1), significantly correlated with RSV‐G expression in HapMap LCLs. Individuals in a case‐control population of RSV‐infected children who were homozygous (n=94) or heterozygous (n=172) for the predicted deleterious A allele in a missense G/A SNP in MX1 had significantly greater risk for developing severe RSV disease relative to those with the major allele (n=108) (χ2 =5.305, P=0.021; OR 1.750, 95% CI: 1.110, 2.758, P=0.021). We conclude that genetically diverse human LCLs enable identification of susceptibility genes (e.g., MX1) for RSV disease severity in children, providing insight for disease risk.—Ciencewicki, J. M., Wang, X., Marzec, J., Serra, M. E., Bell, D. A., Polack, F. P., Kleeberger, S. R. A genetic model of differential susceptibility to human respiratory syncytial virus (RSV) infection. FASEB J. 28, 1947–1956 (2014). www.fasebj.org


EBioMedicine | 2016

Determinants of host susceptibility to murine respiratory syncytial virus (RSV) disease identify a role for the innate immunity scavenger receptor MARCO gene in human infants

Monica High; Hye Youn Cho; Jacqui Marzec; Tim Wiltshire; Kirsten C. Verhein; Mauricio T. Caballero; Patricio L. Acosta; Zackary R. McCaw; Lester Kobzik; Laura Miller-DeGraff; Wes Gladwell; David B. Peden; M. Elina Serra; Min Shi; Clarice R. Weinberg; Oscar Suzuki; Xuting Wang; Douglas A. Bell; Fernando P. Polack; Steven R. Kleeberger

Background Respiratory syncytial virus (RSV) is the global leading cause of lower respiratory tract infection in infants. Nearly 30% of all infected infants develop severe disease including bronchiolitis, but susceptibility mechanisms remain unclear. Methods We infected a panel of 30 inbred strains of mice with RSV and measured changes in lung disease parameters 1 and 5 days post-infection and they were used in genome-wide association (GWA) studies to identify quantitative trait loci (QTL) and susceptibility gene candidates. Findings GWA identified QTLs for RSV disease phenotypes, and the innate immunity scavenger receptor Marco was a candidate susceptibility gene; targeted deletion of Marco worsened murine RSV disease. We characterized a human MARCO promoter SNP that caused loss of gene expression, increased in vitro cellular response to RSV infection, and associated with increased risk of disease severity in two independent populations of children infected with RSV. Interpretation Translational integration of a genetic animal model and in vitro human studies identified a role for MARCO in human RSV disease severity. Because no RSV vaccines are approved for clinical use, genetic studies have implications for diagnosing individuals who are at risk for severe RSV disease, and disease prevention strategies (e.g. RSV antibodies).


Journal of Applied Physiology | 2007

Quantitative trait loci associated with maximal exercise endurance in mice.

J. Timothy Lightfoot; Michael J. Turner; Amy Knab; Anne E. Jedlicka; Tomohiro Oshimura; Jacqui Marzec; Wesley Gladwell; Larry J. Leamy; Steven R. Kleeberger


European Respiratory Journal | 2006

IL18 and IL18R1 polymorphisms, lung CT and fibrosis: a longitudinal study in coal miners

Rachel Nadif; Margaret Mintz; Jacqui Marzec; Anne E. Jedlicka; Francine Kauffmann; Steven R. Kleeberger

Collaboration


Dive into the Jacqui Marzec's collaboration.

Top Co-Authors

Avatar

Steven R. Kleeberger

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Wesley Gladwell

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Hye Youn Cho

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Hye-Youn Cho

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Wes Gladwell

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Douglas A. Bell

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Kirsten C. Verhein

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Michael J. Turner

University of North Carolina at Charlotte

View shared research outputs
Researchain Logo
Decentralizing Knowledge